DUA, KAMAL

Designation/Title : Dr
Department: Pharmaceutical Technology
Tel: +60(3) 2731 7240
Fax:+60-(3) 8656 7228
E-mail : This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

Education and Training

PhD (Pharmaceutical Sciences) Uttar Pradesh Technical University (UPTU), India 2010
M. Pharm (Pharmaceutics) Rajiv Gandhi University of Health Sciences (RGUHS), India 2004(Gold Medalist)
B. Pharm
Maharishi Dayanand University (MDU), India 2002
Professional Diploma in Clinical Research (PDCR) - Catalyst Clinical Services, New Delhi, India 2006
TIFAC-CORE Research Programme in Product Development (TCRP-PD) BR Nahata College of Pharmacy, India 2010
TIFAC-CORE Research Programme in Intellectual Property Rights (TCRP-IPR) BR Nahata College of Pharmacy, India 2011

 

Research interests:

  • Solubilization of poorly water-soluble drugs.
  • Design and Characterization of Topical Drug Delivery Systems, and controlled release transdermal drug delivery systems.

 

Research projects/grants:

  • Preparation, Characterization and In Vitro Evaluation of Ursodeoxycholic Acid (UDCA) Cyclodextrin Inclusion Complexes, IMU Joint-Committee of  Research and the Ethics Committee (IMU-JC),2010 -2011- Principal Researcher
  • Molecular Mechanisms of Minocycline-Induced Suppression of Diabetic Neuropathic Pain in Sprague Dawley Rats IMU Joint-Committee of  Research and the Ethics Committee (IMU-JC), 2010 - 2012- Principal Researcher

 

Supervision of Postgraduates (MSc/PhD)
(Last 5 years – 2008-2012)

  • ....

Professional affiliations:

  • All India Pharmaceutical Teachers Association (APTI) : Life Membership
  • Pharmacy Council of India- Haryana State Branch (PCI) : Life Membership
  • Controlled Release Society- Indian Chapter (CRS-IC) : Life Membership
  • National Intellectual Property Organization (NIPO) : Life Membership
  • Malaysian Pharmaceutical Society (MPS) :Annual Membership
  • Association of Pharmacy Professionals (APP): Life Membership
  • International Society for Infectious Diseases (ISID): Life Membership
  • Pharma Helpline Society (PHS) : Life Membership

 

Academic Awards:

  • Received Sri. K. Sri Harsha Memorial Gold Medal sponsored by Anglo French Drugs & Industries Limited, Bangalore for obtaining 1st rank in M. Pharm Programme of Rajiv Gandhi University of Health Sciences, 2002-04.
  • Received Young Scientist Award-2011 sponsored by Association of Pharmacy Professionals (APP) on the occasion of National Conference on “Current Status & Ongoing Development in Pharmaceutical Research, Bhopal, India, June 2011
  • Awarded with a Fellowship by World Society for Pediatric Infectious Diseases (WSPID) to attend 7th WSPID 2011 at Melbourne, Australia.
  • Awarded Best Poster Presentation at the International Congress of Malaysian Society for Microbiology (ICMSM) 2011, Penang, Malaysia for research work entitled “Antibacterial activity of topical formulations containing silver sulfadiazine and curcuma longa”.
  • Awarded with Honorary Best Poster Presentation at The 14th Biological Sciences Graduate Congress, Chulalongkorn University, Bangkok, Thailand, Dec 2009 for research work entitled “Intestinal absorption of aceclofenac using β-Cyclodextrin: An appraisal”.



Recent publications
(last 5 years – 2008 -2012)

 

Journal

  • Dua K., Leong NK, Kaur M, Bin LW, Azman K, Gorajana A (2012). Preparation, Physicochemical Evaluation and Antimicrobial Potential of Topical Dosage Forms Containing Natural Anti-inflammatory Agent, Curcuma longa, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (In Press)
  • Dua K., Pabreja K., Ramana MV. (2012). Preparation and Characterization of Solid Dispersions of Rofecoxib, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry: 10, (In Press)
  • Dua K., Pabreja K., Ramana MV, Bukhari NI (2011). Preparation, Characterization and In Vitro Evaluation of Aceclofenac PVP-Solid Dispersions, Journal of Dispersion Science and Technology:  32 (8), 1151-1157.
  • Dua K., Pabreja K., Ramana MV. (2011). Enhancement of Dissolution Behaviour of Aceclofenac by complexation with -Cyclodextrin–choline dichloride, Journal of Dispersion Science and Technology: 32(10), 1477-1484.
  • Pabreja K., Dua K., Sharma S., Padi SSV, Kulkarni SK. (2011). Minocycline Attenuates the Development of Diabetic Neuropathy: Possible Anti-inflammatory and Anti-oxidant Mechanisms, European Journal of Pharmacology: 661(1-3), 15-21 , DOI:10.1016/J.Ejphar.2011.04.014.
  • Lim YL, Huan WS, Rajendran A., Adinarayana G., Dua K., Garg S. (2011). Studies on development and dissolution rate of piroxicam using crystal modifications, Acta Pharm.: 61(4):391-402. DOI: 10.2478/v10007-011-0037-z.
  • Dua K., Pabreja K., Ramana MV, Lather V. (2011).Dissolution behaviour Of -Cyclodextrin molecular inclusion complexes of aceclofenac, Journal of Pharmacy and Bioallied Sciences:.3 (3), 417-425.
  • Dua K., Ramana MV, Sara UVS, Pabreja K., Chakravarthi S. (2010). Norfloxacin Transdermal Plasters: A Novel Approach for Burn Wound Healing, ePlasty -Open Access Journal of Plastic Surgery: Vol. 1, 364-382.
  • Dua K., Pabreja K., Ramana MV. (2010). Aceclofenac topical dosage forms: In vitro
    and in vivo characterization, Acta Pharmaceutica: 60, 467–478, DOI: 10.2478/v1007-010-0036-5.
  • Dua K., Pabreja K., Ramana MV. (2010). Preparation, Characterization and In Vitro Evaluation of Aceclofenac Solid Dispersions, ARS Pharmaceutica: 51 (1), 57-76.
  • Dua K., Pabreja K., Ramana MV. (2010). Comparative Investigation on in Vitro release of extemporaneously prepared norfloxacin semisolid formulations with marketed silver sulfadiazine 1% cream, USP using model independent approach, ARS Pharmaceutica: 51 (4):177-185.


Book / Book Chapter

 

  • Dua Kamal, Sharma VK and Pabeja Kavita. OTC Medications, Pharma Med Press (Pharma Book Syndicate), India, 2010,ISBN: 978-81-7800-261-3.
  • Dua Kamal, Pabreja Kavita and Sharma VK. Community Pharmacy: Principle & Concepts, Pharma Med Press (Pharma Book Syndicate), India, 2011, ISBN: 978-93-8107-555-5.


 

This e-mail address is being protected from spambots. You need JavaScript enabled to view it
 

MS ISO/IEC 17025
TESTING
SAMM NO.650